malondialdehyde has been researched along with ligustilide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, JR; Kuang, X; Liu, YX; Qian, ZM; Wang, CY; Yao, Y | 1 |
Feng, ZB; Li, JJ; Lu, YP; Qian, ZM; Zhao, P; Zhu, L; Zhu, Q | 1 |
Alimoradi, H; Baery, N; Barzegar-Fallah, A; Barzegar-Fallah, N; Malekmohammadi, N; Parsa, A; Soleymankhani, M | 1 |
3 other study(ies) available for malondialdehyde and ligustilide
Article | Year |
---|---|
Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice.
Topics: 4-Butyrolactone; Analysis of Variance; Animals; bcl-2-Associated X Protein; Brain Infarction; Caspase 3; Caspases; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione Peroxidase; Immunohistochemistry; Ischemic Attack, Transient; Malondialdehyde; Mice; Mice, Inbred ICR; Neuroprotective Agents; Prosencephalon; Proto-Oncogene Proteins c-bcl-2; Reperfusion; Superoxide Dismutase; Tetrazolium Salts | 2006 |
Ligustilide prevents cognitive impairment and attenuates neurotoxicity in D-galactose induced aging mice brain.
Topics: 4-Butyrolactone; Aging; Animals; Brain; Cognition Disorders; Galactose; GAP-43 Protein; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred ICR; Neuroprotective Agents; Neurotoxicity Syndromes; Sodium-Potassium-Exchanging ATPase; Statistics, Nonparametric | 2015 |
Kelussia odoratissima Mozaff attenuates thromboembolic brain injury, possibly due to its Z-ligustilide content.
Topics: 4-Butyrolactone; Animals; Antioxidants; Apiaceae; Brain Edema; Catalase; Cerebral Cortex; Disease Models, Animal; Glutathione; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Stroke; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |